Preoperative serum c-reactive protein and its prognostic significance in Patients with stage III-IV colorectal cancer

Anticancer Research

Volumn 34, Issue 12, 2014, Pages 7263-7266

  Lumachi, Franco ^a   Basso, Stefano M M ^b   Santeufemia, Davide A ^c   Ermani, Mario ^a   Lo Re, Giovanni ^a   Chiara, Giordano B ^b  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b S MARIA DEGLI ANGELI HOSPITAL   (Italy)

^c Civil Hospital   (Italy)

Author keywords

C Reactive protein; Colorectal cancer; CRP; Prognostic factors

Indexed keywords

C REACTIVE PROTEIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREOPERATIVE EVALUATION; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; RISK FACTOR; SURVIVAL TIME; BLOOD; COLORECTAL TUMOR; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PREOPERATIVE PERIOD; PROPORTIONAL HAZARDS MODEL; SURVIVAL RATE;

AGED; C-REACTIVE PROTEIN; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PREOPERATIVE PERIOD; PROPORTIONAL HAZARDS MODELS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84918534664     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Siegel R, Desantis C and Jemal A: Colorectal cancer statistics, 2014. CA Cancer J Clin 64: 104-117, 2014
2. Haggar FA and Boushey RP: Colorectal cancer epidemiology: Incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg 22: 191-197, 2009
3. OConnell JB, Maggard MA and Ko CY: Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 96: 1420-1425, 2004
4. Quail DF and Joyce JA: Microenvironmental regulation of tumor progression and metastasis. Nat Med 19: 1423-1437, 2013
5. Grivennikov SI, Greten FR and Karin M: Immunity, inflammation, and cancer. Cell 140: 883-899, 2010
6. Rakoff-Nahoum S: Why cancer and inflammation? Yale J Biol Med 79: 123-130, 2006
7. Pepys MB and Hirschfield GM: C-Reactive protein: a critical update. J Clin Invest 111: 1805-1812, 2003
8. Allin KH and Nordestgaard BG: Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer. Crit Rev Clin Lab Sci 48: 155-170, 2011
9. Allin KH, Bojesen SE and Nordestgaard BG: Baseline Creactive protein is associated with incident cancer and survival in patients with cancer. J Clin Oncol 27: 2217-2224, 2009
10. Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ and Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD (USA), 2014
11. Zavoral M, Suchanek S, Zavada F, Dusek L, Muzik J, Seifert B and Fric P: Colorectal cancer screening in Europe. World J Gastroenterol 15: 5907-5915, 2009
12. Terzic J, Grivennikov S, Karin E and Karin M: Inflammation and colon cancer. Gastroenterology 138: 2101-2114, 2010
13. Lin PC, Lin JK, Lin CC, Wang HS, Yang SH, Jiang JK, Lan YT, Lin TC, Li AF, Chen WS and Chang SC: Carbohydrate antigen 19-9 is a valuable prognostic factor in colorectal cancer patients with normal levels of carcinoembryonic antigen and may help predict lung metastasis. Int J Colorectal Dis 27: 1333-1338, 2012
14. Ayude D, Rodruez-Berrocal FJ, Ayude J, Blanco-Prieto S, Vquez-Iglesias L, Vquez-Cedeira M and Puz de la Cadena M: Preoperative serum CA 72.4 as prognostic factor of recurrence and death, especially at TNM stage II, for colorectal cancer. BMC Cancer 13: 543, 2013
15. Volkova E, Willis JA, Wells JE, Robinson BA, Dachs GU and Currie MJ: Association of angiopoietin-2, C-reactive protein and markers of obesity and insulin resistance with survival outcome in colorectal cancer. Br J Cancer 104: 51-59, 2011
16. Choi KW, Hong SW, Chang YG, Lee WY, Lee B, Paik IW and Lee H: Inflammation-based score (Glasgow prognostic score) as an independent prognostic factor in colorectal cancer patients. Ann Surg Treat Res 86: 309-313, 2014
17. Fujii T, Sutoh T, Morita H, Yajima R, Yamaguchi S, Tsutsumi S, Asao T and Kuwano H: Vascular invasion, but not lymphatic invasion, of the primary tumor is a strong prognostic factor in patients with colorectal cancer. Anticancer Res 34: 3147-3151, 2014
18. Ishida K, Nishizuka SS, Chiba T, Ikeda M, Kume K, Endo F, Katagiri H, Matsuo T, Noda H, Iwaya T, Yamada N, Fujiwara H, Takahashi M, Itabashi T, Uesugi N, Maesawa C, Tamura G, Sugai T, Otsuka K, Koeda K and Wakabayashi G: Molecular marker identification for relapse prediction in 5-FU-based adjuvant chemotherapy in gastric and colorectal cancers. PLoS One 7: e43236, 2012
19. Win AK, Hopper JL, Buchanan DD, Young JP, Tenesa A, Dowty JG, Giles GG, Goldblatt J, Winship I, Boussioutas A, Young GP, Parry S, Baron JA, Duggan D, Gallinger S, Newcomb PA, Haile RW, Le Marchand L, Lindor NM and Jenkins MA: Are the common genetic variants associated with colorectal cancer risk for DNA mismatch repair gene mutation carriers? Eur J Cancer 49: 1578-1587, 2013
20. HeikkilK, Ebrahim S and Lawlor DA: A systematic review of the association between circulating concentrations of C reactive protein and cancer. J Epidemiol Community Health 61: 824-833, 2007
21. Su HX, Zhou HH, Wang MY, Cheng J, Zhang SC, Hui F, Chen XZ, Liu SH, Liu QJ, Zhu ZJ, Hu QR, Wu Y and Ji SR: Mutations of C-reactive protein (CRP)-286 SNP, APC and p53 in colorectal cancer: Implication for a CRP-WNT crosstalk. PLoS One 9: e102418, 2014
22. Brull DJ, Serrano N, Zito F, Jones L, Montgomery HE, Rumley A, Sharma P, Lowe GD, World MJ, Humphries SE and Hingorani AD: Human CRP gene polymorphism influences CRP levels: implications for the prediction and pathogenesis of coronary heart disease. Arterioscler Thromb Vasc Biol 23: 2063-2069, 2003
23. Greenfield JR, Samaras K, Jenkins AB, Kelly PJ, Spector TD, Gallimore JR, Pepys MB and Campbell LV. Obesity is an important determinant of baseline serum C-reactive protein concentration in monozygotic twins, independent of genetic influences. Circulation 109: 3022-3028, 2004
24. Chung YC and Chang YF: Serum C-reactive protein correlates with survival in colorectal cancer patients but is not an independent prognostic indicator. Eur J Gastroenterol Hepatol 15: 369-373, 2003
25. Ciccolallo L, Capocaccia R, Coleman MP, Berrino F, Coebergh JW, Damhuis RA, Faivre J, Martinez-Garcia C, Mler H, Ponz de Leon M, Launoy G, Raverdy N, Williams EM and Gatta G: Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis and surgery. Gut 54: 268-273, 2005
26. Tsilidis KK, Branchini C, Guallar E, Helzlsouer KJ, Erlinger TP and Platz EA: C-reactive protein and colorectal cancer risk: a systematic review of prospective studies. Int J Cancer 123: 1133-1140, 2008
27. Aleksandrova K, Jenab M, Boeing H, Jansen E, Bueno-de-Mesquita HB, Rinaldi S, Riboli E, Overvad K, Dahm CC, Olsen A, Tjneland A, Boutron-Ruault MC, Clavel-Chapelon F, Morois S, Palli D, Krogh V, Tumino R, Vineis P, Panico S, Kaaks R, Rohrmann S, Trichopoulou A, Lagiou P, Trichopoulos D, van Duijnhoven FJ, Leufkens AM, Peeters PH, Rodruez L, Bonet C, Schez MJ, Dorronsoro M, Navarro C, Barricarte A, Palmqvist R, Hallmans G, Khaw KT, Wareham N, Allen NE, Spencer E, Romaguera D, Norat T and Pischon T: Circulating C-reactive protein concentrations and risks of colon and rectal cancer: a nested case-control study within the European Prospective Investigation into Cancer and Nutrition. Am J Epidemiol 172: 407-418, 2010
28. Toriola AT, Cheng TY, Neuhouser ML, Wener MH, Zheng Y, Brown E, Miller JW, Song X, Beresford SA, Gunter MJ, Caudill MA and Ulrich CM: Biomarkers of inflammation are associated with colorectal cancer risk in women but are not suitable as early detection markers. Int J Cancer 132: 2648-2658, 2013
29. Swede H, Hajduk AM, Sharma J, Rawal S, Rasool H, Vella AT, Tobet RE and Stevens RG: Baseline serum C-reactive protein and death from colorectal cancer in the NHANES III cohort. Int J Cancer 134: 1862-1870, 2014
30. Akagi T, Inomata M, Kitano S, Hida K, Sakai Y, Hasegawa S, Kinjo Y, Yoshimura K, Ito M, Fukunaga Y, Kanazawa A, Idani H and Watanabe M; Japan Society of Laparoscopic Colorectal Surgery: Multicenter study of short-And long-term outcomes of laparoscopic palliative resection for incurable, symptomatic stage IV colorectal cancer in Japan. J Gastrointest Surg 17: 776-783, 2013.